Yes, we agree on that. And yes, I expect that quarterly revenue growth to decline as a percentage of revenue. I was in fact surprised it went for so long. Still I want to see organic growth ever quarter and the growth should be larger each quarter in real terms, but I will note that there may be some seasonal variance. It's hard to tell with such a young company. As always, need more evidence.
- Forums
- ASX - By Stock
- BIG
- 9 month share price target is +$2.00 share
9 month share price target is +$2.00 share, page-90
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online